Today: 19 May 2026
Browse Category

NYSE:COUR 28 April 2026

Classover Stock Jumps as BlackRock 8% Filing and TIME EdTech Ranking Put KIDZ Back in Focus

Classover Stock Jumps as BlackRock 8% Filing and TIME EdTech Ranking Put KIDZ Back in Focus

Classover Holdings shares jumped Tuesday after BlackRock disclosed an 8% Class B stake and the company reported ranking 122nd on TIME and Statista’s 2026 U.S. edtech list. KIDZ traded at $1.08 late morning, up from $0.97 Monday, with volume at 32.54 million shares. BlackRock reported ownership of 87,463 Class B shares in a Schedule 13G filing. Classover posted 2025 service revenue of $3.37 million and a net loss of $7.04 million.
28 April 2026
··

Stock Market Today

  • Five Stocks to Buy and Hold for Long-Term Wealth Building
    May 18, 2026, 7:43 PM EDT. Investors aiming for long-term wealth should focus on quality businesses suitable for 'buy and forget' strategies, holding through market cycles to allow compounding to maximize returns. Key traits include a strong economic moat, consistent earnings growth, and a commitment to long-term value creation. Leading examples are DBS Group, Southeast Asia's largest bank with a record S$22.9 billion income in FY2025 and a strong 17% return on equity in Q1 2026, outperforming peers OCBC and UOB. Another is ST Engineering, a global tech and defence firm backed by government contracts, boasting a robust order book of S$33.2 billion and planned dividend growth tied to profit increases. Both exemplify stability and growth potential for patient investors.

Latest articles

Agilysys Shares Rise After Earnings Beat

Agilysys Shares Rise After Earnings Beat

19 May 2026
Agilysys shares jumped 16.7% to $81.90 after hours Monday following record fiscal Q4 revenue of $82.9 million and a fiscal 2027 outlook above current sales. Net income for the quarter rose to $12.3 million, or 43 cents a share, from $3.9 million a year earlier. The stock outperformed a weaker tech sector, with the Nasdaq down 0.5%.
Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.

Popular

Super Micro Shares Slip, Eyes on Monday for SMCI

Super Micro Shares Slip, Eyes on Monday for SMCI

18 May 2026
Super Micro Computer shares closed at $31.04 Friday, down 6% on the day and 12.2% since May 8, as the Nasdaq fell 1.54%. The company reports $10.24 billion in March-quarter sales, missing analyst estimates and down from $12.7 billion the prior quarter, with a 9.9% gross margin and $6.6 billion in operating cash outflow. Management will address investors Monday at a J.P. Morgan conference.
Go toTop